Current Location:Home > Company news

On April 26, Dr. Chen Huimin, founder and CEO of SinoBioPrint, was awarded the title of "Chunshen Pyramid Outstanding Talent"

Source:SinoBioPrint (Shanghai) Biotech Ltd.Editor:adminVisit:703Time:2023-04-27

0
图片

  The opening ceremony of the first "Big Zero Bay" International Talent Month was held in the "Big Zero Bay" Kechuang Building on April 26.

图片图片

  Cao Yuanfeng, Executive Vice Minister of Organization Department of Shanghai Municipal Committee and Executive Deputy Director of Talent Office of Shanghai Municipal Committee, Li Zhigang, Vice President of China Talent Research Society and former Deputy director of Talent Work Bureau of the Organization Department of Shanghai Municipal Committee, Chen Yujian, Secretary of the District Party Committee, Chen Huwen, Deputy secretary of the District Party Committee, Tang Jinsong, deputy secretary of the District Party Committee and so on attended the event. Honors such as "Big Zero Bay Talent Initiative Award", "Chunshen Pyramid Outstanding Talent Medal" and "Shanghai Haiju Talents" Innovation and Entrepreneurship Demonstration Base will be conferred on the spot.

图片

△Second from left in the photo is

Dr. Chen Huimin, founder and CEO of SinoBioPrint

  Dr. Chen Huimin, founder and CEO of SinoBioPrint, was awarded the title of "Chunshen Pyramid Outstanding Talent". This is not only the affirmation of his hard entrepreneurial spirit, but also the affirmation of the Chinese SinoBioPrint innovation ability.

图片

  SinoBioPrint provides Chinese solution for cartilage regeneration and repair, and we believe it will bring good news to more patients. We focus on the clinical transformation of biological 3D printing in the fields of sports medicine, orthopedics and plastic surgery. Adhering to the values of "focus, excellence and universal benefit", the company is striving forward in the biological 3D printing technology platform and the innovative medical equipment circuit, contributing to the construction of a healthy China. Look forward to working with scientific research institutions, industrial upstream and downstream companies and investment and financing companies in a wider range, deeper fields and higher levels of cooperation, welcome to contact and exchange.